Lorillard
Rule 26 Expert Report Dr. Arthur C. Upton
Fields
- Author
- Upton, A.C.
- Area
- LEGAL DEPT. FILE ROOM/CENTRAL FILES
- Document File
- 82390800/82391190/Litigation Mclean V. Philip Morris, Et Al. Court Papers - Volume II
- 82390801/82391189/Litigation Mclean V. Philip Morris, Et Al. Court Papers Volume II
- Type
- RESU, RESUME
- Litigation
- Feda/Produced
- Named Organization
- Environmental + Occupational Health Inst
- Howarth Smith
- Robert Wood Johnson Medical School
- Howarth Smith
- Site
- N14
- Named Person
- Huth, M.
- Mclean, L.
- Upton, A.C.
- Mclean, L.
- Request
- R1-080
- Date Loaded
- 20 Dec 2001
- UCSF Legacy ID
- ncc62d00
Document Images
B. P_rofessional Memberships
Since 1957, I have served on a number of cancer research
project committees. From 1958-1960, I served on the Advisory
Committee on Research on Etiology of Cancer, for the American
Cancer Society and in 1963 I served on the Expert Panel on
Carcinogenicity for the International Cancer Research Commission
of the International Union Against Cancer. In 1964, I was
appointed by President Johnson to head the National Institutes of
Health Study Committee Panel on Pathology under Secretary of
Health, Education and Welfare, Joseph Califano. From 1967-1969,
I served on the committee of American Association for Cancer
Research as Representative to USA National Academy of Sciences-
National Research Council. From 1972-1973 and 1974-1977, I
worked on the Carcinogenesis Advisory Board and the Board of
Scientific Councillors Advisory Group, U.S.-Japan Cooperative
Cancer Research Program for the National Cancer Institute. From
1977- 1979, I was Chairman of the Governing Council for the World
Health Organization, International Agency for Research on Cancer.
From 1981-1982, I was Chairman of the Public Issues Committee for
the American Association for Cancer Research.
C. Honorary Membershins
I have been a member of the following:
1) American Association for Advancement of Science
2) American Association for Cancer Research
3) American Association of Pathologists and
B
i
l
i
t
t
er
o
s
ac
og
s
4) American College of Toxicology
5) American Society for Experimental Pathology
6) American Society for Investigative Pathology
7) Armed Forces Institute of Pathology
8) New York Pathological Society
9) International Academy of Pathology
10) Society for Risk Analysis
D. Honors
and Awards
I have received the following professional honors and
awards:
1) Comfort Crookshank Award for Cancer Research, 1978
2) Japanese Cancer Association, Honorary Member, 1979
3) Institute of Medicine, National Academy of
4) Sciences, 1979
Claude M. Fuess Award, 1980
Page 2 of 17

Rule 26 Expert Report
DR. ARTHUR C. UPTON
I. INTRODUCTION
My name is Arthur C. Upton. My business address is Robert
Wood Johnson Medical School, Environmental and Occupational
Health Institute, 170 Freling Huysem Rd., Piscata Way, New
Jersey, 08854. I was retained by Plaintiffs' counsel Howarth &
Smith, on behalf of Plaintiffs Lilo McLean and Mark Huth, to
consult in the case of McLean et al. v. R.J. Reynolds, et al. My
rate for consulting and court or deposition testimony is $200 per
hour.
II. BACKGROUND AND EDUCATION
I was born in Ann Arbor, Michigan. I have been a medical
doctor and pathologist for over 40 years. I studied for six
years and graduated from the University of Michigan, in 1946,
receiving both BA and MD degrees. After receiving my MD degree,
I did three years of residency at University Hospital, Ann Arbor,
Michigan and became a board certified pathologist specializing in
anatomy. I have been a member in good standing with the American
Board of Pathology since 1952.
A. Professional Experience
After receiving my MD and BA degrees from the University of
Michigan, I held positions as Pathologist and Chief of the
Pathology-Physiology Section at Oak Ridge National Laboratory
from 1951 to 1969. From 1969 to 1975, I held positions as
Professor of Pathology, Chairman of the Department of Pathology
and Dean of the School of Basic Health Sciences at State
University of New York at Stony Brook. I also served as Captain
in the United States Armed Forces from 1955 to 1970 and R.
Admiral, in the United States Public Health Services from 1977
to the present. From 1961- 1964, I held offices as member of the
Board of Directors, Vice-President and President of the American
Association for Cancer Research. From 1966-19b8, I held offices
as Councilor, Vice-President and President of the American
Society for Experimental Pathology. From 1977-1979 I was the
Director of the National Cancer Institute. Presently, I am on
the Board of Directors for both the Society for the Study of
Comparative Oncology and the International Consortium for
Research on the Health Effects of Radiation.
Page 1 of 17

33) Lorillard Creative Research Director Writes Professor
Charles Seide, Cooper Union re Creating a Package Appealing
to Kids, 8/13/70
34) WSJ Article (7/21/95) "Letter From a Tobacco Company to an
Art Professor, August 1970"
35) B&W Letter From David Hardy, Shook, Hardy, Ottoman, Mitchell
& Bacon, to Debaun Bryant, 8/20/70
37) RJR Memo From Mike Jordan to S&H Attorneys, 4/29/88, "John
Robinson's California Cases"
38) Letter From John Heller of New England Institute For Medical
Research, Inc. to Dr. Robert N. Dupuis of Philip Morris
39) Lisher & Company, Inc., Marketing Management Consultants'
Proposal For Low Delivery Project For Brown And Williamson
40) "Tobacco: The Controversy Is Real" by William Kloepfer, The
Tobacco Institute
41) "Survey of Cancer Research With Emphasis Upon Possible
Carcinogens From Tobacco"
42) Tobacco Industry Research Committee Report, Statement by The
Scientific Director, November 8,1957, Attachment #2
43) RJR Scientific Advisory Board Luncheon Meeting Minutes,
Informational Memorandum, November 11, 1957
44) Philip Morris Memo from J.E. Lincoln to R.R. Milhiser re
"Two Complexes, a Compound and a Campaign", April 23, 1958
45) RJR Report "Research Planning Memorandum on the Nature of
the Tobacco Business and the Crucial Role of Nicotine
Therein"
46) RJR Report "Strategic Research Report - Younger Adult
Smokers: Strategies and Opportunities", February 29, 1984
47) RJR Memos to Sales Reps From J.P. McMahon re Young Adult
Market Targeting High Schools, January 10, 1990
48) RJR Memo from R.G. Warlick to All Representatives re Young
Adult Market-targeting High Schools SIS Accounting Group,
April 5, 1990
Co
tV
(N
Page 10 of 17 ~D
~
~
c.n
rn

5) IBM-Princess Takamatsu Cancer Research Foundation,
Lecturer, 1981
6) Failla Memorial Lecturer, Health Physics Society,
Greater New York Chapter, 1983
7) CHUMS Physician-of-the-Year Award, 1985
8) Basic Cell Research in Cytology Lectureship Award,
1985
9) New-York Academy of Sciences, Honorary Life
Member, 1991
10) Fellow, American Association for Advancement of
Science
11) National Council on Radiation Protection and
Measurement, Honorary Member, 1992
12) Lovelace Medical Foundation Award for Excellence
in Environmental Research, 1993
13) Distinguished Life Membership, American Registry
of Pathology, Armed Forces Institute of Pathology,
1993
14) 1997 Distinguished Achievement Award, Society for
Risk Analysis
E.
Teaching Positions
I was an Instructor of Pathology at the University of
Michigan Medical School from 1950-1951. From 1969-1977, I was
the Professor of Pathology in the Health Sciences Center at State
University of New York at Stony Brook. From 1980-1992, I was
Professor and Chairman of the Department of Environmental
Medicine at New York University, School of Medicine. At the
University of New Mexico School of Medicine, I was Clinical
Professor of Pathology from 1992-1995 and Clinical Professor of
Radiology from 1993 to the present. Currently I am Clinical
Professor of Environmental & Community Medicine at UMDNJ-Robert
Wood Johnson Medical School.
III. PUBLICATIONS
I have authored over 350 published articles, books and
reports. These include:
1) The Radiobiology of the Cancer Cell, Federation
Proceedings, Vol. 17, 698-713 (1958).
2) Current Trends of Cancer Research, 6th IBM
Medical Svmnosium, 591-600 (1964).
3) Summary Report of the Chairman. National Cancer
Program Planning Conference, National Cancer
00
!V
Page 3 of 17 W
~
~
~
.~
~

Carcinoma of the Lung", published in the British Medical Journal
in 1950. The scientific evidence and literature also confirms
that cigarette smoking causes approximately 30 diseases,
including various types of cancer, as well as vascular diseases,
respiratory diseases, and gastrointestinal diseases. For
example, see "The Relationship between Human Smoking Habits and
Death Rates", By E. Hammond and D. Horn (referenced above)and
also "Effect of Smoking on the Production and Maintenance of
Gastric and Duodenal Ulcers" in Lancet Vol. 1 (at pp. 657-662),
By Doll R., Jones F.A., and Pygott F.
Based on the Declaration of Ted Huth, David McLean's brother,
the Depositions of Lilo McLean, David McLean's widow, and Mark
Huth, his son, in addition to the smoking history in the medical
records, David McLean began smoking cigarettes in approximately
1934, when he was 12 or 13 years old. He continued to smoke
approximately one to two packs a day, although he occasionally
smoked as much as five packs in a day in Marlboro commercials, up
until 1993, when he was forced to quit smoking because of surgery
to remove his lung cancer. it is my medical opinion that David
McLean's lung cancer, cardiovascular disease and chronic
obstructive pulmonary disease were caused by his cigarette
smoking.
Based on my review of David McLean's medical records, David
McLean's pathology reports, David McLean's Death Certificate, and
the slides of tissue samples taken from David McLean's
thoracoscopy and abdomen surgery, it is my opinion that David
McLean died from carcinoma of the lung, and that his lung cancer
was caused by his lifetime history of smoking cigarettes.
3. Mr. McLean's Addiction to Cigarette Smoking
Dr. Matthew Connolly, M.D. and clinical pharmacologist, who
treated David McLean for extreme pain in the last stages of his
terminal cancer, has concluded based on his personal knowledge of
the patient and his smoking history that David McLean became
addicted to smoking in his early adolescence, at approximately 12
or 13 years of age; I concur with Dr. Connolly's diagnosis based
on the materials I reviewed independently, including Mr. McLean's
medical records and smoking history, and based on the medical
literature on addiction.
Page 14 of 17

Institute, National Institutes of Health, U.S.
Department of Health, Education and Welfare,
Washington, D.C. (1975).
4) The National Cancer Institute and its Redefined
Mission, Grants Magazine, 1:113-128 (1978).
5) "Future Directions in Cancer Prevention",
(Preventive Medicine 9:309-314, 1980)
6) Cancer, By Upton A.C. and Golumbia N., Medical and
Health Annual Encyclopedia Britanica, Chicago
(1979).
7) Consensus Conference on Screening for Lung Cancer,
By Fink D.J. and Upton A.C., Vet. Human Toxicol.,
21:339-352 (1979).
8) "Environmental Causes of Cancer" (In:
Anticarcinogenesis and Radiation Protection,
edited by O.F. Nygaard and A.C. Upton, Plenum
Press, New York, 1991, pp. 13-20).
9) Cancer Induction and Nonstochastic Effects,
British Journal of Radioloav, 60: 1-16 (1987).
10) Carcinogenic Risk Assessment in Proper
Perspective, Toxicology and Industrial Health,
4:443-452 (1988).
IV. CASES
The following are cases for which I testified as an expert
either in deposition or at trial within the last four years:
Glen James, et a1. v. Southern California Edison Co., United
States District Court, Southern District of California, Case No.
94-1085-J. (Deposition testimony, March 24, 1995; trial
testimony, September 7, 1995.)
V. MATERIALS REVIEWED
In preparation for forming the opinions expressed below, in
addition to the pathology research and cancer studies I have
personally conducted over the course of my career, I have
reviewed the following materials:
A.
I have reviewed the medical records of David McLean from the
UCLA Medical Center, the UCLA Pain Center, Saint John's Hospital
and Health Center, California Rehabilitation Medical Center, Hill
and Cornell, M.D., American Eye Institute, Veteran's
Administration Hospital, Cedars-Sinai Medical Center, Marvin J.
Rapaport, M.D., Brotman Medical Center, Martin Cooper, M.D.,
CC)
ND
Page 4 of 17 w
w
~
~
cn
O

i
Morris, Inc., Liggett & Myers, Inc., Liggett Group, Inc., Brooke
Group, Inc., R.J. Reynolds Tobacco Co., Brown & Williamson
Tobacco Co., The American Tobacco Co., B.A.T. Industries P.L.C.,
British-American Tobacco Co., and by the Council for Tobacco
Research - U.S.A., Inc., and the Tobacco Institute, Inc. Please
see below for a list of documents reviewed:
1) Advertisement: "All the Fuss about smoking got me thinking
I'd either quit or smoke True. I smoke True"
2) Memorandum from J.K. Wells, re: Document Retention dated
1/17/85
3) Memorandum from J.K. Wells, re: Southampton Smoking and
Health material dated 6/15/79
4) Memorandum from J.K. Wells to E. Pepples, re: BAT Science
dated 2/17/86
5) Memorandum from E. E. Kohnhorst from E. Pepples dated
8/16/84
6) Handbook For Leaf Blenders and Product Developers dated
2/1991
7) "Can we have an open debate about smoking?" published by RJR
8) "Youth" dated 1987
9) Statements by James Johnston dated 4/14/94
10) Letter from J.P. McMahon dated 1/10/90
11) Letter from J.P. McMahon dated 5/3/90
12) Memorandum dated 7/3/74 re: records an act, condition or
event at or near the time of the act, condition, or event.
13) Letter from Jo F. Spach dated 1/11/90
14) Research Planning Memorandum on Some Thoughts About
New Brands of Cigarettes For the Youth Market
15) "Frank Statement to Cigarette Smokers", 1954
16) Conversations With Dr. S.J. Green, Head of Research at BAT,
1/81
w
Iv
Page 8 of 17 Cni
~
~
Cn
.p.

Nicotine-Containing Cigarettes" by David Kessler, M.D.,
House Subcommittee on Health and the Environment, March
25, 1994 and the "Statement by David Kessler, M.D.,
Commissioner of Food and Drugs on th~e Control and
Manipulation of Nicotine in Cigarettes", June 21, 1994.
12) "Smoking and Carcinoma of the Lung", Preliminary
Report, By Doll R and Hill AB, British Medical Journal,
Vol 2, 739, (1950).
13) "Cancer of the Lung in Relation to Tobacco", By Da ff
M.E., Doll R., and Kennaway E.L., British Journal of
Cancer, Vol. 5, 1-20 (1951).
14) "A Study of Aetiology of Carcinoma of the Lung", B y
Doll R. and Hill A.B., British Medical Journal, Vol . 2,
1271 (1952).
15) "Smoking and Carcinoma of the Lung", By Doll R.,
Acta Un internat contr Cancer, Vol. 9, 495 (1953).
16) "Mortality in Relation to Smoking: Ten years'
Observations of British Doctors", By Doll R. and Hill
A.B., British Medical Journal, Vol. 1, 1339-1410, 1460-
1467 (1964).
17) "Mortality in Relation to Smoking: Forty years'
Observation on Male British Doctors", By Doll R.,
Peto R., Wheatley K., Gray R., and Sutherland I.,
British Medical Journal, Vol. 309 (October 8,
1994).
18) "The Relationship between Human Smoking Habits and
Death Rates", By Hammond E. and Horn D., JAMA
(August 7, 1954).
19) "Prying Open the Door to the Tobacco Industry's
Secrets About Nicotine", By Hurt R. and Robertson
C., JAMA (October 7, 1998).
20) "Effect of Smoking on the Production and Maintenance of
Gastric and Duodenal Ulcers", By Doll R., Jones F.A.,
and Pygott F., Lancet Vol. 1, 657-662 (1958).
E. Tobacco Company Documents
I have reviewed a number of documents, including internal
memos and studies, and reports, articles and advertisements
published by the major tobacco companies, including Philip
Page 7 of 17

Dennis Evangelatos, M.D., Diagnostic Radiology, Antoine Hage,
M.D., Lebovic, Schwimer, Goldberg, M.D.s, Richard M. Protzel,
M.D., Michael Levine, M.D., Country Villa Westwood, Bob Hope
Health Center, Mitchell D. Covel, M.D., Melani Shaum, M.D., Gray
Bellack, M.D., Kenneth M. Tokita, M.D., Tower Radiology Medical
Group, Neurological Rehab. Associates, Mason Hohl, M.D.
I have reviewed a letter from Dr. Matthew Connolly
concerning David McLean's addiction to tobacco.
I have reviewed the death certificate for David McLean,
identifying the cause of death as "metastatic carcinoma of the
lung", and two pathology reports on David McLean, from 1993 and
1995.
B. Tissue Sambles
I have examined prepared and stained slides of
tissue samples taken from David McLean, sent to me from the UCLA
Pathology Department. The tissue samples were taken from his
thoracoscopy in 1993 and his 1988 abdominal surgery.
C. David McLean's Smoking History
In addition to the letter from Dr. Connolly, I have reviewed
the following: the March 3, 1998, Declaration of Ted Huth, David
McLean's brother, which states that David McLean began smoking
when he was approximately 12 years old; the February 16-17, 1998,
Deposition of Lilo McLean, David McLean's widow, which describes,
among other things, his smoking history and his medical
treatment; and the February 17, 1998, Deposition of Mark Huth,
David McLean's son. There is also discussion of his smoking
history in the medical records.
D. Medical and Scientific Literature
In addition to my education, background, training, and
experiences in cancer research, I have reviewed medical and
scientific articles and studies on: (1) the link between tobacco,
including cigarette smoking, and cancer and other diseases; (2)
the medical community's awareness of the causal connection
between tobacco and cancer, including lung cancer; (3) the
medical community's awareness of the causal connection between
cigarette smoking and other health problems related to cigarette
smoke, including but not limited to, chronic obstructive
pulmonary disease, including emphysema, and cardiovascular
disease; and (4) the medical community's awareness of nicotine
Page 5 of 17

49) RJR Memo from F.H. Christopher, Jr. re "What Causes Smokers
to Select Their First Brand of Cigarettes", July 3, 1974
50) RJR Memo re "Research Planning Memorandum on Some Thoughts
About New Brands of Cigarettes For The Youth Market",
2/2/73.
51) "Implications of Battele Hippo I&TI And The Griffith
Filter", 7/17/63
52) BAT Co. Ltd - Minnesota Tobacco Litigation, Draft Report -
Key Areas Product Innovatior. Over Next 10 Years For Long
Term Development, 8/28/79
53) Arthur D. Little, Inc. Report "L&M - a Perspective Review"'
March 15, 1961
54) Philip Morris, Motives And Incentives in Cigarette Smoking,
William L. Dunn, Jr, w/chart
55) Memo From L.L. Long to R.B. Salignon re "Project Review
1960 Cigarette", June 3, 1960
56) Phillip Morris "Outline of The Research And Development
Objectives For 1961" Presented to The R&D Committee by H.
Wakeham, January 12, 1961
57) Philip Morris Advertisement, -What Does Philip Morris Have
to Say About The Allegation of 'Nicotine Manipulation'
58) Philip Morris "Facts You Should Know" Advertisement
59) B&W Meeting Notes For 12/17/65 re Ctr, Expenses & General
Counsel
60) Tobacco Industry Research Committee "A Frank Statement to
The Public by The Makers of Cigarettes, 12/28/65
61) The American Tobacco Company President Paul Hahn's Letter to
John Hill re The Policy of The Tobacco Institute
62) Memo from Fred Panzer to Horace Kornegay re the Roper
Proposal, May 1, 1972
63) Memo From C.V. Mace to Dr. Dupuis re "Brief Comments on a
Program to Produce a Low Delivery Filter Cigarette With
Flavor", July 24, 1958.
Page 11 of 17
